ELIDEL / serious adverse reactions in nursing infants
United States · event evidence
serious adverse reactions in nursing infants
Under review
The label identifies a potential risk from pimecrolimus in nursing infants.
- Authority
- DailyMed, U.S. National Library of Medicine
- Document
- ELIDEL (PIMECROLIMUS) CREAM [PHYSICIANS TOTAL CARE, INC.]
- Jurisdiction
- United States
- Version / revision
- 1
- Document date
- Not recorded
Source evidence
Because of the potential for serious adverse reactions in nursing infants from pimecrolimus
- Section
- Not stated
- Context
- The label identifies a potential risk from pimecrolimus in nursing infants.
- Frequency
- Not stated
- Population / denominator
- Not stated
Return to label evidence explorer